Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 412
- 试验地点
- 1
- 主要终点
- Metabolic ratios
研究概览
简要总结
The Cytochrome P450 enzymes are responsible for the metabolism of a wide range of drugs and other xenobiotics. Genetic variants of the encoding P450 genes have shown to influence the rate of metabolism of many clinically used drugs.
The drugs tramadol, omeprazole, losartan, quinidine and caffeine reflect the activity of CYP2D6 (tramadol), CYP2C19 (omeprazole), CYP2C9 (losartan), CYP1A2 (caffeine) and CYP3A4/5 (quinidine).
The aim of the study is to investigate if the cocktail of tramadol, omeprazole, losartan and caffeine can be used to simultaneously determine the activity of CYP2D6, CYP2C19, CYP2C9 and CYP1A2. Furthermore, will the natural occurring 4-beta-hydroxy-cholesterol in the blood be measured as a metric for CYP3A4/5.
The study is divided in two. First part will include 12 healthy volunteers and consists of three arms separated by at least one week. In the first arm 50 mg of tramadol will be ingested and urine will be collected for 8 hours. In the second arm 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs. In the last arm 50 mg of tramadol, 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs.
Metabolic ratios will be calculated based on urine and plasma concentrations of the drugs and the relevant metabolites. Relevant genetic variants of the cytochrome P450 encoding genes will be determined.
If the metabolic ratios of the drugs are not significantly different between the arms, Second part of the study will be conducted.
This part is identical with the last arm and will include a maximum of 400 healthy volunteers: 50 mg of tramadol, 20 mg omeprazole, 25 mg losartan and 200 mg caffeine will be ingested followed by 8 hours urine collection and a blood sample 4 hours after administration of the drugs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers,
- •Written consent, AND
- •Age 18-65 years old.
排除标准
- •Daily medication,
- •Alcohol abuse,
- •Pregnancy, OR
- •Breastfeeding.
研究组 & 干预措施
Tramadol
CYP2D6 metric
干预措施: Tramadol (Drug)
Omeprazole, losartan, caffeine
CYP2C19, CYP2C9 and CYP1A2 metrics
干预措施: Omeprazole, losartan, caffeine (Drug)
Tramadol, omeprazole, losartan and caffeine
CYP2D6, CYP2C19, CYP2C9 and CYP1A2 metrics
干预措施: Tramadol, omeprazole, losartan, caffeine (Drug)
结局指标
主要结局
Metabolic ratios
时间窗: January 2011
次要结局
- Genetic variants(January 2011)
